Source:http://linkedlifedata.com/resource/pubmed/id/18249147
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2008-4-21
|
pubmed:abstractText |
Diabetes mellitus is a chronic disease characterized by an overproduction of reactive oxygen species, which perturbs zinc metabolism and promotes the onset of cardiovascular disease (CVD) in diabetic patients. Metallothioneins (MT) are cysteine-rich metal-binding proteins which, by means of their antioxidant and zinc-buffering properties, might prevent the development of diabetic cardiovascular complications. A recent investigation shows that a polymorphism (+647 A/C) in the human MT-1A gene, affects the intracellular zinc ion release (iZnR) from the proteins and is associated with longevity in Italian population. The aim of the present study is to assess the involvement of +647 A/C and +1245 A/G MT1A polymorphisms with the susceptibility to type 2 diabetes (DM2) and cardiovascular complications. The study included 694 old individuals: 242 old healthy controls, 217 DM2 patients without clinical evidence of CVD (DNC) and 235 diabetic patients with diagnosis of CVD (DCVD). +647 A/C MT1A polymorphism, but not the second SNP, was associated with DM2. C allele carriers were more prevalent in DNC and DCVD patients than in control group (OR=1.37, p=0.034; OR=1.54, p=0.002, respectively). C+ carriers was associated with higher glycemia and glycosylated hemoglobin in DCVD patients, but not in DNC or control subjects. No differences in plasma zinc, but a modulation of MT levels and iZnR in PBMCs were observed in DCVD cohort when related to +647 A/C MT1A polymorphism. In summary, this work provides novel evidence on the association of the +647 A/C MT1A polymorphism with DM2. Moreover, C+ carriers in DCVD patients presented a worse glycemic control, a reduced iZnR and a higher MT levels, suggesting a possible role of MT in diabetic cardiovascular complications.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1096-7206
|
pubmed:author |
pubmed-author:BonfigliA RAR,
pubmed-author:CiprianoCC,
pubmed-author:CostarelliLL,
pubmed-author:GiacconiRR,
pubmed-author:MalavoltaMM,
pubmed-author:MarraMM,
pubmed-author:MocchegianiEE,
pubmed-author:MuthDD,
pubmed-author:PiacenzaFF,
pubmed-author:SirollaCC,
pubmed-author:TeseiSS,
pubmed-author:TestaRR
|
pubmed:issnType |
Electronic
|
pubmed:volume |
94
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
98-104
|
pubmed:meshHeading |
pubmed-meshheading:18249147-Aged,
pubmed-meshheading:18249147-Cardiovascular Diseases,
pubmed-meshheading:18249147-Diabetes Complications,
pubmed-meshheading:18249147-Diabetes Mellitus, Type 2,
pubmed-meshheading:18249147-Female,
pubmed-meshheading:18249147-Flow Cytometry,
pubmed-meshheading:18249147-Genetic Predisposition to Disease,
pubmed-meshheading:18249147-Humans,
pubmed-meshheading:18249147-Male,
pubmed-meshheading:18249147-Metallothionein,
pubmed-meshheading:18249147-Middle Aged,
pubmed-meshheading:18249147-Polymorphism, Single Nucleotide,
pubmed-meshheading:18249147-Zinc
|
pubmed:year |
2008
|
pubmed:articleTitle |
+647 A/C and +1245 MT1A polymorphisms in the susceptibility of diabetes mellitus and cardiovascular complications.
|
pubmed:affiliation |
Immunology Center (Section Nutrition, Immunity and Ageing), Research Department INRCA, via Birarelli 8, 60121 Ancona, Italy. rogiacconi@libero.it
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|